Using a high-throughput proteomic approach, label-free liquid chromatography–tandem mass spectrometry of cerebrospinal fluid (CSF) samples from DLB patients identified PCSK1N, NPTXR, VGF, PDYN, SCG2, and NPTX2. Here, SCG2 is linked to Lewy body dementia.